Delivery Order SPE2DB25D9312-SPE2DB25FWUWV
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for LENVIMA 18 mg daily dose medication (90-unit supply) with a ceiling value of $22.7K. The award, issued on September 10, 2025, utilizes a firm fixed-price contract structure with an ultimate completion date of October 1, 2025. This delivery order carries no set-aside designation, allowing DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on September 10, 2025, by the Defense Logistics Agency for the supply of Lenvima 14 mg daily dose medication in quantities of 60 units. This firm fixed-price delivery order, valued at $11,353.77, is scheduled for completion by October 1, 2025, with no set-aside designation applied. The award represents a continuation of DMS Pharmaceutical Group's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $124,891.53 for LENVIMA 20 mg daily dose medication (60-unit supply) by the Defense Logistics Agency's Medical Supply Chain on September 15, 2025. This delivery order, which carries no set-aside designation, is part of DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $11,353.77 by the Defense Logistics Agency (DLA) on September 16, 2025. The contract calls for the delivery of Lenvima 20 mg daily dose tablets in quantities of 60 units, with an ultimate completion date of October 7, 2025. This delivery order was issued without a set-aside designation, leveraging the contractor's competitive...
- The U.S. Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. for LENVIMA 20 mg daily dose (60-count supply) valued at $11,353.77 on August 21, 2025, with completion expected by September 12, 2025. This firm fixed-price delivery order was awarded without set-aside designation to the Park Ridge, Illinois-based woman-owned small business pharmaceutical wholesaler. The award is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $11,353.77 by the Defense Logistics Agency on August 22, 2025, for the supply of Lenvima 8 mg daily dose tablets (60-count). This firm fixed-price delivery order is scheduled for completion by September 15, 2025, with performance taking place at the vendor's Park Ridge location. The award was made without a set-aside designation, reflecting...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $22.7 thousand on August 22, 2025, for the supply of LENVIMA 14 mg daily dose medication in quantities of 60 units. The delivery order carries an ultimate completion date of September 15, 2025, and will be performed at the awardee's Park Ridge location. This award was issued without a set-aside designation and is funded by...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for LENVIMA 8 mg daily dose tablets (60-count supply) with a ceiling value of $11,353.77. This firm fixed-price delivery order, awarded on August 28, 2025, with an ultimate completion date of September 19, 2025, represents a procurement of a specialized oncology medication. The contract carries no set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $11,353.77 by the Defense Logistics Agency on September 9, 2025, for the supply of Lenvima 10 mg daily dose tablets (30-count packaging). The contract carries an ultimate completion date of September 30, 2025, and includes no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's existing Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lenvima 8 mg daily dose tablets in quantities of 60 units. This firm fixed-price delivery order, valued at $11,353.77, was awarded on September 10, 2025, with an ultimate completion date of October 1, 2025. The contract contains no set-aside designation, allowing DMS Pharmaceutical Group to compete...
- SPE2DB25D9312Indefinite Delivery Contract
- SPE2DB25D9312-SPE2DB25FWUWVDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 17, 2025, for LENVIMA 8 mg daily dose medication (60-count supply). The contract is valued at $29,624.58 and operates under a firm fixed-price delivery order structure with an ultimate completion date of October 8, 2025. This award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open federal procurement market based on its established capabilities and pricing. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA's SPE2DB program, a $499.9 billion vehicle through November 2026 that enables the agency to procure comprehensive pharmaceutical products supporting Department of Defense healthcare facilities worldwide. The single-award IDC encompasses branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. LENVIMA, an oncology treatment medication, aligns with the contract's portfolio of specialty pharmaceutical products serving military health system requirements. As a consistent performer on DLA pharmaceutical supply contracts since 2001, DMS Pharmaceutical Group maintains a significant role in the federal pharmaceutical supply chain distribution network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.6k | 9/17/25 |